{"id":"https://openalex.org/W7223957009","doi":"https://doi.org/10.1155/cdr/7328020","title":"PCSK9 and Atrial Fibrillation: A New Perspective on an Old Problem","display_name":"PCSK9 and Atrial Fibrillation: A New Perspective on an Old Problem","publication_year":2026,"publication_date":"2026-01-01","ids":{"openalex":"https://openalex.org/W7223957009","doi":"https://doi.org/10.1155/cdr/7328020","pmid":"https://pubmed.ncbi.nlm.nih.gov/42935110","pmcid":"https://www.ncbi.nlm.nih.gov/pmc/articles/13710888"},"language":"en","primary_location":{"id":"doi:10.1155/cdr/7328020","doi":"https://doi.org/10.1155/cdr/7328020","is_oa":true,"landing_page_url":"https://doi.org/10.1155/cdr/7328020","pdf_url":"https://onlinelibrary.wiley.com/doi/pdfdirect/10.1155/cdr/7328020","source":{"id":"https://openalex.org/S73613154","display_name":"Cardiovascular Therapeutics","issn_l":"1755-5914","issn":["1755-5914","1755-5922"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-c","jufo-1","ki-jl-1","medline","norway-1","poland-100","russia-white-list-2"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cardiovascular Therapeutics","raw_type":"journal-article"},"volume":null,"type":"review","is_traditional":true,"indexed_in":["crossref","doaj","pubmed"],"open_access":{"is_oa":true,"oa_status":"gold","oa_url":"https://onlinelibrary.wiley.com/doi/pdfdirect/10.1155/cdr/7328020","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5036163332","display_name":"Amirhossein Sahebkar","orcid":"https://orcid.org/0000-0002-8656-1444","observed_orcids":["https://orcid.org/0000-0002-8656-1444","https://orcid.org/0000-0003-1747-8353"]},"institutions":[{"id":"https://openalex.org/I165560825","display_name":"Mashhad University of Medical Sciences","ror":"https://ror.org/04sfka033","country_code":"IR","type":"education","lineage":["https://openalex.org/I165560825"]},{"id":"https://openalex.org/I74319210","display_name":"Chitkara University","ror":"https://ror.org/057d6z539","country_code":"IN","type":"education","lineage":["https://openalex.org/I74319210"]}],"countries":["IN","IR"],"is_corresponding":true,"raw_author_name":"Amirhossein Sahebkar","raw_affiliation_strings":["Applied Biomedical Research Center Basic Sciences Research Institute Mashhad University of Medical Sciences  Mashhad Iran  mums.ac.ir","Biotechnology Research Center Pharmaceutical Technology Institute School of Pharmacy Mashhad University of Medical Sciences  Mashhad Iran  mums.ac.ir","Centre for Research Impact & Outcome Chitkara College of Pharmacy Chitkara University  Rajpura Punjab India  chitkara.edu.in"],"raw_orcid":"https://orcid.org/0000-0002-8656-1444","affiliations":[{"raw_affiliation_string":"Applied Biomedical Research Center Basic Sciences Research Institute Mashhad University of Medical Sciences  Mashhad Iran  mums.ac.ir","institution_ids":["https://openalex.org/I165560825"]},{"raw_affiliation_string":"Biotechnology Research Center Pharmaceutical Technology Institute School of Pharmacy Mashhad University of Medical Sciences  Mashhad Iran  mums.ac.ir","institution_ids":["https://openalex.org/I165560825"]},{"raw_affiliation_string":"Centre for Research Impact & Outcome Chitkara College of Pharmacy Chitkara University  Rajpura Punjab India  chitkara.edu.in","institution_ids":["https://openalex.org/I74319210"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5062034086","display_name":"Wael A. Almahmeed","orcid":"https://orcid.org/0000-0003-0312-9910","observed_orcids":["https://orcid.org/0000-0003-0312-9910"]},"institutions":[{"id":"https://openalex.org/I4405266839","display_name":"Cleveland Clinic Abu Dhabi","ror":"https://ror.org/00042rr39","country_code":"AE","type":"healthcare","lineage":["https://openalex.org/I4405266839"]}],"countries":["AE"],"is_corresponding":false,"raw_author_name":"Wael Almahmeed","raw_affiliation_strings":["Heart and Vascular Institute Cleveland Clinic Abu Dhabi  Abu Dhabi UAE  clevelandclinicabudhabi.ae"],"raw_orcid":"https://orcid.org/0000-0003-0312-9910","affiliations":[{"raw_affiliation_string":"Heart and Vascular Institute Cleveland Clinic Abu Dhabi  Abu Dhabi UAE  clevelandclinicabudhabi.ae","institution_ids":["https://openalex.org/I4405266839"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5045032651","display_name":"Prashant Kesharwani","orcid":"https://orcid.org/0000-0002-0890-769X","observed_orcids":["https://orcid.org/0000-0002-0890-769X"]},"institutions":[{"id":"https://openalex.org/I101407740","display_name":"Chandigarh University","ror":"https://ror.org/05t4pvx35","country_code":"IN","type":"education","lineage":["https://openalex.org/I101407740"]},{"id":"https://openalex.org/I8977528","display_name":"Dr. Hari Singh Gour University","ror":"https://ror.org/01xapxe37","country_code":"IN","type":"education","lineage":["https://openalex.org/I8977528"]}],"countries":["IN"],"is_corresponding":true,"raw_author_name":"Prashant Kesharwani","raw_affiliation_strings":["Next-Generation Translational Nanomedicine Laboratory Department of Pharmaceutical Sciences Dr. Harisingh Gour Vishwavidyalaya (A Central University)  Sagar Madhya Pradesh India","University Institute of Pharma Sciences Chandigarh University  Mohali Punjab India  chandigarhuniversity.ac.in"],"raw_orcid":"https://orcid.org/0000-0002-0890-769X","affiliations":[{"raw_affiliation_string":"Next-Generation Translational Nanomedicine Laboratory Department of Pharmaceutical Sciences Dr. Harisingh Gour Vishwavidyalaya (A Central University)  Sagar Madhya Pradesh India","institution_ids":["https://openalex.org/I8977528"]},{"raw_affiliation_string":"University Institute of Pharma Sciences Chandigarh University  Mohali Punjab India  chandigarhuniversity.ac.in","institution_ids":["https://openalex.org/I101407740"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5054750006","display_name":"Tannaz Jamialahmadi","orcid":"https://orcid.org/0000-0001-9521-3153","observed_orcids":["https://orcid.org/0000-0001-9521-3153"]},"institutions":[{"id":"https://openalex.org/I165560825","display_name":"Mashhad University of Medical Sciences","ror":"https://ror.org/04sfka033","country_code":"IR","type":"education","lineage":["https://openalex.org/I165560825"]}],"countries":["IR"],"is_corresponding":false,"raw_author_name":"Tannaz Jamialahmadi","raw_affiliation_strings":["Pharmaceutical Research Center Pharmaceutical Technology Institute School of Pharmacy Mashhad University of Medical Sciences  Mashhad Iran  mums.ac.ir"],"raw_orcid":"https://orcid.org/0000-0001-9521-3153","affiliations":[{"raw_affiliation_string":"Pharmaceutical Research Center Pharmaceutical Technology Institute School of Pharmacy Mashhad University of Medical Sciences  Mashhad Iran  mums.ac.ir","institution_ids":["https://openalex.org/I165560825"]}]}],"institutions":[],"countries_distinct_count":3,"institutions_distinct_count":5,"corresponding_author_ids":["https://openalex.org/A5036163332","https://openalex.org/A5045032651"],"corresponding_institution_ids":["https://openalex.org/I101407740","https://openalex.org/I165560825","https://openalex.org/I74319210","https://openalex.org/I8977528"],"apc_list":{"value":2160,"currency":"USD","value_usd":2160},"apc_paid":{"value":2160,"currency":"USD","value_usd":2160},"fwci":0.0,"has_fulltext":true,"cited_by_count":0,"citation_normalized_percentile":{"value":0.63409091,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":null,"biblio":{"volume":"2026","issue":"1","first_page":null,"last_page":null},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10065","display_name":"Atrial Fibrillation Management and Outcomes","score":0.9574999809265137,"subfield":{"id":"https://openalex.org/subfields/2705","display_name":"Cardiology and Cardiovascular Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10065","display_name":"Atrial Fibrillation Management and Outcomes","score":0.9574999809265137,"subfield":{"id":"https://openalex.org/subfields/2705","display_name":"Cardiology and Cardiovascular Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10394","display_name":"Lipoproteins and Cardiovascular Health","score":0.009800000116229057,"subfield":{"id":"https://openalex.org/subfields/2705","display_name":"Cardiology and Cardiovascular Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10881","display_name":"Blood Coagulation and Thrombosis Mechanisms","score":0.00430000014603138,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/pcsk9","display_name":"PCSK9","score":0.9980000257492065},{"id":"https://openalex.org/keywords/atrial-fibrillation","display_name":"atrial fibrillation","score":0.9950000047683716},{"id":"https://openalex.org/keywords/pcsk9-inhibitors","display_name":"PCSK9 inhibitors","score":0.9779999852180481},{"id":"https://openalex.org/keywords/alirocumab","display_name":"alirocumab","score":0.9779999852180481},{"id":"https://openalex.org/keywords/evolocumab","display_name":"evolocumab","score":1.0},{"id":"https://openalex.org/keywords/inclisiran","display_name":"inclisiran","score":1.0},{"id":"https://openalex.org/keywords/platelet-activation","display_name":"platelet activation","score":0.9850000143051147},{"id":"https://openalex.org/keywords/oxidative-stress","display_name":"oxidative stress","score":1.0},{"id":"https://openalex.org/keywords/vascular-calcification","display_name":"vascular calcification","score":0.9990000128746033},{"id":"https://openalex.org/keywords/atrial-remodeling","display_name":"atrial remodeling","score":0.9819999933242798},{"id":"https://openalex.org/keywords/cardiovascular-events","display_name":"cardiovascular events","score":0.4659999907016754}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.9524999856948853},{"id":"https://openalex.org/C2780948078","wikidata":"https://www.wikidata.org/wiki/Q21130010","display_name":"PCSK9","level":5,"score":0.9013000130653381},{"id":"https://openalex.org/C2779161974","wikidata":"https://www.wikidata.org/wiki/Q815819","display_name":"Atrial fibrillation","level":2,"score":0.776199996471405},{"id":"https://openalex.org/C2778824825","wikidata":"https://www.wikidata.org/wiki/Q7250439","display_name":"Proprotein convertase","level":5,"score":0.6123999953269958},{"id":"https://openalex.org/C535046627","wikidata":"https://www.wikidata.org/wiki/Q30612","display_name":"Clinical trial","level":2,"score":0.5016999840736389},{"id":"https://openalex.org/C203092338","wikidata":"https://www.wikidata.org/wiki/Q1340863","display_name":"Clinical endpoint","level":3,"score":0.4844000041484833},{"id":"https://openalex.org/C12713177","wikidata":"https://www.wikidata.org/wiki/Q1900281","display_name":"Perspective (graphical)","level":2,"score":0.48410001397132874},{"id":"https://openalex.org/C168563851","wikidata":"https://www.wikidata.org/wiki/Q1436668","display_name":"Randomized controlled trial","level":2,"score":0.48019999265670776},{"id":"https://openalex.org/C177713679","wikidata":"https://www.wikidata.org/wiki/Q679690","display_name":"Intensive care medicine","level":1,"score":0.4388999938964844},{"id":"https://openalex.org/C164705383","wikidata":"https://www.wikidata.org/wiki/Q10379","display_name":"Cardiology","level":1,"score":0.4041999876499176},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.39100000262260437},{"id":"https://openalex.org/C2993857929","wikidata":"https://www.wikidata.org/wiki/Q1773974","display_name":"Primary prevention","level":3,"score":0.3596999943256378},{"id":"https://openalex.org/C2778849439","wikidata":"https://www.wikidata.org/wiki/Q6397985","display_name":"Kexin","level":5,"score":0.35749998688697815},{"id":"https://openalex.org/C61511704","wikidata":"https://www.wikidata.org/wiki/Q1671857","display_name":"Incidence (geometry)","level":2,"score":0.35530000925064087},{"id":"https://openalex.org/C2779473830","wikidata":"https://www.wikidata.org/wiki/Q1540899","display_name":"MEDLINE","level":2,"score":0.298799991607666},{"id":"https://openalex.org/C60644358","wikidata":"https://www.wikidata.org/wiki/Q128570","display_name":"Bioinformatics","level":1,"score":0.27079999446868896},{"id":"https://openalex.org/C2909914741","wikidata":"https://www.wikidata.org/wiki/Q256289","display_name":"Endpoint Determination","level":3,"score":0.2702000141143799},{"id":"https://openalex.org/C2778384578","wikidata":"https://www.wikidata.org/wiki/Q16930687","display_name":"Therapeutic approach","level":3,"score":0.2694000005722046},{"id":"https://openalex.org/C3019550498","wikidata":"https://www.wikidata.org/wiki/Q28749","display_name":"Ldl cholesterol","level":3,"score":0.25859999656677246}],"mesh":[{"descriptor_ui":"D000071449","descriptor_name":"Proprotein Convertase 9","qualifier_ui":"Q000097","qualifier_name":"blood","is_major_topic":true},{"descriptor_ui":"D000071449","descriptor_name":"Proprotein Convertase 9","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":true},{"descriptor_ui":"D000091362","descriptor_name":"PCSK9 Inhibitors","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000818","descriptor_name":"Animals","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000889","descriptor_name":"Anti-Arrhythmia Agents","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D001281","descriptor_name":"Atrial Fibrillation","qualifier_ui":"Q000097","qualifier_name":"blood","is_major_topic":true},{"descriptor_ui":"D001281","descriptor_name":"Atrial Fibrillation","qualifier_ui":"Q000175","qualifier_name":"diagnosis","is_major_topic":true},{"descriptor_ui":"D001281","descriptor_name":"Atrial Fibrillation","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D001281","descriptor_name":"Atrial Fibrillation","qualifier_ui":"Q000201","qualifier_name":"enzymology","is_major_topic":true},{"descriptor_ui":"D001281","descriptor_name":"Atrial Fibrillation","qualifier_ui":"Q000453","qualifier_name":"epidemiology","is_major_topic":true},{"descriptor_ui":"D001281","descriptor_name":"Atrial Fibrillation","qualifier_ui":"Q000503","qualifier_name":"physiopathology","is_major_topic":true},{"descriptor_ui":"D001281","descriptor_name":"Atrial Fibrillation","qualifier_ui":"Q000517","qualifier_name":"prevention & control","is_major_topic":true},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D012307","descriptor_name":"Risk Factors","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D015398","descriptor_name":"Signal Transduction","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D015842","descriptor_name":"Serine Proteinase Inhibitors","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D015842","descriptor_name":"Serine Proteinase Inhibitors","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D016896","descriptor_name":"Treatment Outcome","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D018384","descriptor_name":"Oxidative Stress","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D050171","descriptor_name":"Dyslipidemias","qualifier_ui":"Q000097","qualifier_name":"blood","is_major_topic":true},{"descriptor_ui":"D050171","descriptor_name":"Dyslipidemias","qualifier_ui":"Q000175","qualifier_name":"diagnosis","is_major_topic":true},{"descriptor_ui":"D050171","descriptor_name":"Dyslipidemias","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D050171","descriptor_name":"Dyslipidemias","qualifier_ui":"Q000201","qualifier_name":"enzymology","is_major_topic":true},{"descriptor_ui":"D050171","descriptor_name":"Dyslipidemias","qualifier_ui":"Q000453","qualifier_name":"epidemiology","is_major_topic":true},{"descriptor_ui":"D064752","descriptor_name":"Atrial Remodeling","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":4,"locations":[{"id":"doi:10.1155/cdr/7328020","doi":"https://doi.org/10.1155/cdr/7328020","is_oa":true,"landing_page_url":"https://doi.org/10.1155/cdr/7328020","pdf_url":"https://onlinelibrary.wiley.com/doi/pdfdirect/10.1155/cdr/7328020","source":{"id":"https://openalex.org/S73613154","display_name":"Cardiovascular Therapeutics","issn_l":"1755-5914","issn":["1755-5914","1755-5922"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-c","jufo-1","ki-jl-1","medline","norway-1","poland-100","russia-white-list-2"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cardiovascular Therapeutics","raw_type":"journal-article"},{"id":"pmh:oai:pubmedcentral.nih.gov:13710888","doi":null,"is_oa":true,"landing_page_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC13710888/","pdf_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC13710888/pdf/CDR-2026-7328020.pdf","source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cardiovasc Ther","raw_type":"Text"},{"id":"pmid:42935110","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/42935110","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cardiovascular therapeutics","raw_type":"Journal Article"},{"id":"pmh:oai:doaj.org/article:16c3b54564e44efdb5e9577a006d4622","doi":null,"is_oa":false,"landing_page_url":"https://doaj.org/article/16c3b54564e44efdb5e9577a006d4622","pdf_url":null,"source":{"id":"https://openalex.org/S4306401280","display_name":"DOAJ (DOAJ: Directory of Open Access Journals)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"Cardiovascular Therapeutics, Vol 2026 (2026)","raw_type":"article"}],"best_oa_location":{"id":"doi:10.1155/cdr/7328020","doi":"https://doi.org/10.1155/cdr/7328020","is_oa":true,"landing_page_url":"https://doi.org/10.1155/cdr/7328020","pdf_url":"https://onlinelibrary.wiley.com/doi/pdfdirect/10.1155/cdr/7328020","source":{"id":"https://openalex.org/S73613154","display_name":"Cardiovascular Therapeutics","issn_l":"1755-5914","issn":["1755-5914","1755-5922"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-c","jufo-1","ki-jl-1","medline","norway-1","poland-100","russia-white-list-2"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cardiovascular Therapeutics","raw_type":"journal-article"},"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":1.0}],"study_designs":[],"awards":[{"id":"https://openalex.org/G2909801169","display_name":null,"funder_award_id":"4026662","funder_id":"https://openalex.org/F4320322243","funder_display_name":"Iran National Science Foundation"}],"funders":[{"id":"https://openalex.org/F4320322243","display_name":"Iran National Science Foundation","ror":"https://ror.org/03sr1ma14"}],"has_content":{"pdf":true,"grobid_xml":true},"content_urls":{"pdf":"https://content.openalex.org/works/W7223957009.pdf","grobid_xml":"https://content.openalex.org/works/W7223957009.grobid-xml"},"referenced_works_count":51,"referenced_works":["https://openalex.org/W1525222882","https://openalex.org/W1971505725","https://openalex.org/W2075782700","https://openalex.org/W2145838023","https://openalex.org/W2407343790","https://openalex.org/W2609836833","https://openalex.org/W2623414143","https://openalex.org/W2625125262","https://openalex.org/W2727479556","https://openalex.org/W2755021631","https://openalex.org/W2828351338","https://openalex.org/W2953868838","https://openalex.org/W2955932804","https://openalex.org/W2990333463","https://openalex.org/W3000776376","https://openalex.org/W3014207761","https://openalex.org/W3157921250","https://openalex.org/W3165247221","https://openalex.org/W3217545445","https://openalex.org/W4206912654","https://openalex.org/W4213015985","https://openalex.org/W4221061009","https://openalex.org/W4229031518","https://openalex.org/W4250821772","https://openalex.org/W4281385813","https://openalex.org/W4286008006","https://openalex.org/W4297177888","https://openalex.org/W4306314964","https://openalex.org/W4322761896","https://openalex.org/W4327681880","https://openalex.org/W4383711438","https://openalex.org/W4385709012","https://openalex.org/W4386212287","https://openalex.org/W4386630416","https://openalex.org/W4393231703","https://openalex.org/W4394765917","https://openalex.org/W4399138769","https://openalex.org/W4399790764","https://openalex.org/W4401232106","https://openalex.org/W4403680208","https://openalex.org/W4404921348","https://openalex.org/W4405425844","https://openalex.org/W4406052826","https://openalex.org/W4407878540","https://openalex.org/W4411537850","https://openalex.org/W4412490635","https://openalex.org/W4417153560","https://openalex.org/W7127367285","https://openalex.org/W7129576203","https://openalex.org/W7136115690","https://openalex.org/W7155648880"],"related_works":["https://openalex.org/W4229031518","https://openalex.org/W2763899764","https://openalex.org/W7164162332","https://openalex.org/W4406212072","https://openalex.org/W4386630416","https://openalex.org/W4409740048","https://openalex.org/W2755021631","https://openalex.org/W7155356235","https://openalex.org/W4414420000","https://openalex.org/W2981478430"],"abstract_inverted_index":{"Proprotein":[0],"convertase":[1],"subtilisin/kexin":[2],"type":[3],"9":[4],"(PCSK9)":[5],"has":[6],"emerged":[7],"as":[8,44,74],"a":[9,75],"novel":[10],"contributor":[11],"to":[12,88],"atrial":[13,39],"fibrillation":[14],"(AF)":[15],"pathophysiology.":[16],"Recent":[17],"studies":[18],"suggest":[19],"that":[20],"elevated":[21],"PCSK9":[22,41,94],"levels":[23],"may":[24],"promote":[25],"AF":[26,57,73,96],"through":[27],"multiple":[28],"mechanisms,":[29],"including":[30],"platelet":[31],"activation,":[32],"oxidative":[33],"stress,":[34],"vascular":[35],"calcification,":[36],"and":[37,47,59,83,98],"structural":[38],"remodeling.":[40],"inhibitors":[42],"such":[43],"alirocumab,":[45],"evolocumab,":[46],"newer":[48],"agents":[49],"like":[50],"inclisiran":[51],"have":[52],"shown":[53],"potential":[54],"in":[55,63,95],"reducing":[56],"incidence":[58],"cardiovascular":[60],"events,":[61],"particularly":[62],"high-risk":[64],"populations.":[65],"However,":[66],"evidence":[67],"from":[68],"randomized":[69],"controlled":[70],"trials":[71],"with":[72],"primary":[76],"clinical":[77],"endpoint":[78],"is":[79,86],"limited.":[80],"Further":[81],"mechanistic":[82],"interventional":[84],"research":[85],"warranted":[87],"establish":[89],"optimized":[90],"therapeutic":[91],"strategies":[92],"targeting":[93],"prevention":[97],"management.":[99]},"counts_by_year":[],"updated_date":"2026-11-06T12:05:46.655746","created_date":"2026-10-28T00:00:00"}